Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 9519718, 14 pages
https://doi.org/10.1155/2018/9519718
Review Article

The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases

1Department of Clinical Veterinary Medicine, College of Veterinary Medicine, China Agricultural University, Beijing, China
2Abdul Wali Khan University, Garden Campus, Khyber Pakhtunkhwa, Pakistan
3Department of Biosciences, COMSATS Institute of Information Technology (CIIT), Bioscience Block, Chak Shahzad Campus, Park Road, Islamabad, Pakistan
4Department of Animal Nutrition, The University of Agriculture, Peshawar, Pakistan

Correspondence should be addressed to Sadeeq ur Rahman; kp.ude.mukwa@qeedaS and Jian Gao; nc.ude.uac@6102naijoag

Received 2 November 2017; Revised 24 January 2018; Accepted 31 January 2018; Published 26 March 2018

Academic Editor: Yun-Peng Chao

Copyright © 2018 Sadeeq ur Rahman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Piet, P. Van Ulsen, S. Ur Rahman et al., “Meningococcal two-partner secretion systems and their association with outcome in patients with meningitis,” Infection and Immunity, vol. 84, no. 9, pp. 2534–2540, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Ur Rahman, J. Arenas, H. Öztürk, N. Dekker, and P. Van Ulsen, “The polypeptide transport-associated (POTRA) domains of TpsB transporters determine the system specificity of two-partner secretion systems,” The Journal of Biological Chemistry, vol. 289, no. 28, pp. 19799–19809, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Ur Rahman and P. van Ulsen, “System specificity of the TpsB transporters of coexpressed two-partner secretion systems of Neisseria meningitidis,” Journal of Bacteriology, vol. 195, no. 4, pp. 788–797, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Van Ulsen, S. U. Rahman, W. S. P. Jong, M. H. Daleke-Schermerhorn, and J. Luirink, “Type V secretion: from biogenesis to biotechnology,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1843, no. 8, pp. 1592–1611, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Wright, “The penicillins,” Mayo Clinic Proceedings, vol. 74, no. 3, pp. 290–307, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. B. H. Normark and S. Normark, “Evolution and spread of antibiotic resistance,” Journal of Internal Medicine, vol. 252, no. 2, pp. 91–106, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. J. N. Samaha-Kfoury and G. F. Araj, “Recent developments in β lactamases and extended spectrum β lactamases,” British Medical Journal, vol. 327, no. 7425, pp. 1209–1213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Finch, P. Davey, M. H. Wilcox, and W. Irving, Antimicrobial Chemotherapy, Oxford University Press, 2012. View at Publisher · View at Google Scholar
  9. E. P. Abraham and E. Chain, “An enzyme from bacteria able to destroy penicillin [1],” Nature, vol. 146, no. 3713, p. 837, 1940. View at Publisher · View at Google Scholar · View at Scopus
  10. G.-Y. Tan, Y. Peng, C. Lu, L. Bai, and J.-J. Zhong, “Engineering validamycin production by tandem deletion of γ-butyrolactone receptor genes in Streptomyces hygroscopicus 5008,” Metabolic Engineering, vol. 28, pp. 74–81, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. T.-C. Zhou and J.-J. Zhong, “Production of validamycin A from hemicellulose hydrolysate by Streptomyces hygroscopicus 5008,” Bioresource Technology, vol. 175, pp. 160–166, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Čižman, “The use and resistance to antibiotics in the community,” International Journal of Antimicrobial Agents, vol. 21, no. 4, pp. 297–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. D. D. Pitout, C. C. Sanders, and W. E. Sanders Jr., “Antimicrobial resistance with focus on β-lactam resistance in gram- negative bacilli,” American Journal of Medicine, vol. 103, no. 1, pp. 51–59, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. G. A. Jacoby and L. S. Munoz-Price, “The new beta-lactamases,” The New England Journal of Medicine, vol. 352, no. 4, pp. 380–391, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Fosse, C. Giraud-Morin, I. Madinier, and R. Labia, “Sequence analysis and biochemical characterisation of chromosomal CAV-1 (Aeromonas caviae), the parental cephalosporinase of plasmid-mediated AmpC "FOX" cluster,” FEMS Microbiology Letters, vol. 222, no. 1, pp. 93–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. B. Avison, P. Niumsup, T. R. Walsh, and P. M. Bennett, “Aeromonas hydrodphila AmpH and CepH β-lactamases: derepressed expression in mutants of Escherichia coli lacking creB,” Journal of Antimicrobial Chemotherapy, vol. 46, no. 5, pp. 695–702, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. B. A. Rasmussen, D. Keeney, Y. Yang, and K. Bush, “Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 9, pp. 2078–2085, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. M. V. Hayes, C. J. Thomson, and S. G. B. Amyes, “Three beta-lactamases isolated from Aeromonas salmonicida, including a carbapenemase not detectable by conventional methods,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 13, no. 10, pp. 805–811, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. T. R. Walsh, L. Hall, A. P. Macgowan, and P. M. Bennett, “Sequence analysis of two chromosomally mediated inducible β-lactamases from aeromonas sobria, strain 163a, one a class d penicillinase, the other an ampc cephalosporinase,” Journal of Antimicrobial Chemotherapy, vol. 36, no. 1, pp. 41–52, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Fihman, M. Rottman, Y. Benzerara et al., “BUT-1: a new member in the chromosomal inducible class C β-lactamases family from a clinical isolate of Buttiauxella sp,” FEMS Microbiology Letters, vol. 213, no. 1, pp. 103–111, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Naas, D. Aubert, N. Fortineau, and P. Nordmann, “Cloning and sequencing of the β-lactamase gene and surrounding DNA sequences of Citrobacter braakii, Citrobacter murliniae, Citrobacter werkmanii, Escherichia fergusonii and Enterobacter cancerogenus,” FEMS Microbiology Letters, vol. 215, no. 1, pp. 81–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Lindberg and S. Normark, “Sequence of the Citrobacter freundii OS60 chromosomal ampCβ‐lactamase gene,” The FEBS Journal, vol. 156, no. 3, pp. 441–445, 1986. View at Publisher · View at Google Scholar · View at Scopus
  23. M. B. Avison, S. Underwood, A. Okazaki, T. R. Walsh, and P. M. Bennett, “Analysis of AmpC β-lactamase expression and sequence in biochemically atypical ceftazidime-resistant Enterobacteriaceae from paediatric patients,” Journal of Antimicrobial Chemotherapy, vol. 53, no. 4, pp. 584–591, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Stock and B. Wiedemann, “Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 8, pp. 2245–2255, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Nadjar, R. Labia, C. Cerceau, C. Bizet, A. Philippon, and G. Arlet, “Molecular characterization of chromosomal class C β-lactamase and its regulatory gene in Ochrobactrum anthropi,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 8, pp. 2324–2330, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Rottman, Y. Benzerara, B. Hanau-Berçot, C. Bizet, A. Philippon, and G. Arlet, “Chromosomal ampC genes in Enterobacter species other than Enterobacter cloacae, and ancestral association of the ACT-1 plasmid-encoded cephalosporinase to Enterobacter asburiae,” FEMS Microbiology Letters, vol. 210, no. 1, pp. 87–92, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Galleni, F. Lindberg, S. Normark et al., “Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products.,” Biochemical Journal, vol. 250, no. 3, pp. 753–760, 1988. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Jaurin and T. Grundstrom, “ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type,” in Proceedings of the National Acadamy of Sciences of the United States of America, vol. 78, pp. 4897–4901, 1981. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Girlich, T. Naas, S. Bellais, L. Popirel, A. Karim, and P. Nordmann, “Heterogeneity of AmpC cephalosporinase of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 11, pp. 3220–3223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Poirel, M. Guibert, D. Girlich, T. Naas, and P. Nordmann, “Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 4, pp. 769–776, 1999. View at Google Scholar · View at Scopus
  31. N. A. C. Curtis, R. L. Eisenstadt, C. Rudd, and A. J. White, “Inducible type i βlactamases of gram-negative bacteria and resistance to βlactam antibiotics,” Journal of Antimicrobial Chemotherapy, vol. 17, no. 1, pp. 51–61, 1986. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Joris, F. de Meester, M. Galleni et al., “Properties of a class C β-lactamase from Serratia marcescens,” Biochemical Journal, vol. 239, no. 3, pp. 581–586, 1986. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Schumacher, M. Nir, B. Mansa, and A. Grassy, “β‐lactamases in Shigella: brief report,” APMIS-Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 100, no. 7-12, pp. 954–956, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Seoane, M. V. Francia, and J. M. G. Lobo, “Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica,” Antimicrobial Agents and Chemotherapy, vol. 36, no. 5, pp. 1049–1052, 1992. View at Publisher · View at Google Scholar · View at Scopus
  35. L. D. Sabath, M. Jago, and E. P. Abraham, “Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea.,” Biochemical Journal, vol. 96, no. 3, pp. 739–752, 1965. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Michaux, J. Massant, F. Kerff et al., “Crystal structure of a cold-adapted class C β-lactamase,” FEBS Journal, vol. 275, no. 8, pp. 1687–1697, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Feller, Z. Zekhnini, J. Lamotte-Brasseur, and C. Gerday, “Enzymes from cold-adapted microorganisms. The class C β-lactamase from the antarctic psychrophile Psychrobacter immobilis A5,” European Journal of Biochemistry, vol. 244, no. 1, pp. 186–191, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. W. E. Farrar Jr. and N. M. O'Dell, “β-Lactamase activity in Chromobacterium violaceum,” The Journal of Infectious Diseases, vol. 134, no. 3, pp. 290–293, 1976. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Bauernfeind, S. Schweighart, and Y. Chong, “Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins,” Infection, vol. 17, no. 5, pp. 316–321, 1989. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Bauernfeind, I. Stemplinger, R. Jungwirth, R. Wilhelm, and Y. Chong, “Comparative characterization of the cephamycinase bla(CMY-1) gene and its relationship with other β-lactamase genes,” Antimicrobial Agents and Chemotherapy, vol. 40, no. 8, pp. 1926–1930, 1996. View at Google Scholar · View at Scopus
  41. A. Bauernfeind, I. Stemplinger, R. Jungwirth, and H. Giamarellou, “Characterization of the plasmidic β-lactamase CMY-2, which is responsible for cephamycin resistance,” Antimicrobial Agents and Chemotherapy, vol. 40, no. 1, pp. 221–224, 1996. View at Google Scholar · View at Scopus
  42. G. A. Jacoby and J. Tran, “Sequence of the MIR-1 β-lactamase gene,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 7, pp. 1759-1760, 1999. View at Google Scholar · View at Scopus
  43. T. Horii, Y. Arakawa, M. Ohta, S. Ichiyama, R. Wacharotayankun, and N. Kato, “Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam,” Antimicrobial Agents and Chemotherapy, vol. 37, no. 5, pp. 984–990, 1993. View at Publisher · View at Google Scholar · View at Scopus
  44. M. G. Leiza, J. C. Perez-Diaz, J. Ayala et al., “Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 9, pp. 2150–2157, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. O. Gaillot, C. Clément, M. Simonet, and A. Philippon, “Novel transferable β-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis,” Journal of Antimicrobial Chemotherapy, vol. 39, no. 1, pp. 85–87, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. P. A. Bradford, C. Urban, N. Mariano, S. J. Projan, J. J. Rahal, and K. Bush, “Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 3, pp. 563–569, 1997. View at Google Scholar · View at Scopus
  47. A. Bauernfeind, I. Schneider, R. Jungwirth, H. Sahly, and U. Ullmann, “A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 8, pp. 1924–1931, 1999. View at Google Scholar · View at Scopus
  48. D. Girlich, T. Naas, S. Bellais, L. Poirel, A. Karim, and P. Nordmann, “Biochemical-genetic characterization and regulation of expression of an ACC-1-like chromosome-borne cephalosporinase from Hafnia alvei,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 6, pp. 1470–1478, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Nakano, R. Okamoto, Y. Nakano et al., “CFE-1, a Novel Plasmid-Encoded AmpC β-Lactamase with an ampR Gene Originating from Citrobacter freundii,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 4, pp. 1151–1158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. S. C. Parija, Textbook of Microbiology & Immunology, Elsevier Health Sciences, 2014.
  51. A. Zapun, C. Contreras-Martel, and T. Vernet, “Penicillin-binding proteins and β-lactam resistance,” FEMS Microbiology Reviews, vol. 32, no. 2, pp. 361–385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. I. Massova and S. Mobashery, “Kinship and diversification of bacterial penicillin-binding proteins and β-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 1, pp. 1–17, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Fedarovich, R. A. Nicholas, and C. Davies, “The role of the β5-α11 loop in the active-site dynamics of acylated penicillin-binding protein A from Mycobacterium tuberculosis,” Journal of Molecular Biology, vol. 418, no. 5, pp. 316–330, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. A. H. Delcour, “Outer membrane permeability and antibiotic resistance,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1794, no. 5, pp. 808–816, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. X. Z. Li and H. Nikaido, “Efflux-mediated drug resistance in bacteria: an update,” Drugs, vol. 69, no. 12, pp. 1555–1623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Bush and G. A. Jacoby, “Updated functional classification of β-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 3, pp. 969–976, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. J. D. D. Pitout, “Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices,” Drugs, vol. 70, no. 3, pp. 313–333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. R. P. Ambler, A. F. W. Coulson, J.-M. Frere et al., “A standard numbering scheme for the class A β-lactamases,” Biochemical Journal, vol. 276, no. 1, pp. 269-270, 1991. View at Publisher · View at Google Scholar · View at Scopus
  59. G. A. Jacoby, “AmpC β-lactamases,” Clinical Microbiology Reviews, vol. 22, no. 1, pp. 161–182, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. K. L. Chew, R. T. Lin, and J. W. Teo, “Klebsiella pneumoniae in Singapore: hypervirulent infections and the carbapenemase threat,” Frontiers in Cellular and Infection Microbiology, vol. 7, 2017. View at Publisher · View at Google Scholar
  61. J. C. Cho, M. A. Fiorenza, and S. J. Estrada, “Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination,” Pharmacotherapy, vol. 35, no. 7, pp. 701–715, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Geisinger and R. R. Isberg, “Interplay between antibiotic resistance and virulence during disease promoted by multidrug-resistant bacteria,” The Journal of Infectious Diseases, vol. 215, no. 1, pp. S9–S17, 2017. View at Publisher · View at Google Scholar · View at Scopus
  63. R. A. Powers, “Structural and functional aspects of extended-spectrum ampc cephalosporinases,” Current Drug Targets, vol. 17, no. 9, pp. 1051–1060, 2016. View at Publisher · View at Google Scholar · View at Scopus
  64. A. M. Queenan, B. Foleno, C. Gownley, E. Wira, and K. Bush, “Effects of inoculum and β-Lactamase activity in AmpC- and extended-Spectrum β-Lactamase (ESBL)-producing escherichia coli and klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology,” Journal of Clinical Microbiology, vol. 42, no. 1, pp. 269–275, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. W.-H. Zhao and Z.-Q. Hu, “Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria,” Critical Reviews in Microbiology, vol. 39, no. 1, pp. 79–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Cantón, J. M. González-Alba, and J. C. Galán, “CTX-M enzymes: origin and diffusion,” Frontiers in Microbiology, vol. 3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Birbrair and P. S. Frenette, “Niche heterogeneity in the bone marrow,” Annals of the New York Academy of Sciences, vol. 1370, no. 1, pp. 82–96, 2016. View at Publisher · View at Google Scholar · View at Scopus
  68. M. M. D'Andrea, F. Arena, L. Pallecchi, and G. M. Rossolini, “CTX-M-type β-lactamases: a successful story of antibiotic resistance,” International Journal of Medical Microbiology, vol. 303, no. 6-7, pp. 305–317, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. S. B. Levy, “Factors impacting on the problem of antibiotic resistance,” Journal of Antimicrobial Chemotherapy, vol. 49, no. 1, pp. 25–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Oliver, J. C. Pérez-Díaz, T. M. Coque, F. Baquero, and R. Cantón, “Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-10) isolated in Spain,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 2, pp. 616–620, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Karim, L. Poirel, S. Nagarajan, and P. Nordmann, “Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1,” FEMS Microbiology Letters, vol. 201, no. 2, pp. 237–241, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. L. B. Rice, S. H. Willey, G. A. Papanicolaou et al., “Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility,” Antimicrobial Agents and Chemotherapy, vol. 34, no. 11, pp. 2193–2199, 1990. View at Publisher · View at Google Scholar · View at Scopus
  73. C. D. Steward, D. Wallace, S. K. Hubert et al., “Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories,” Diagnostic Microbiology and Infectious Disease, vol. 38, no. 1, pp. 59–67, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Alsterlund, B. Carlsson, L. Gezelius, S. Hæggman, and B. Olsson-Liljequist, “Multiresistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: description of an outbreak,” Infectious Diseases, vol. 41, no. 6-7, pp. 410–415, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. M. F. Vázquez, J. L. Muñoz Bellido, M. I. García García, and J. A. García-Rodríguez, “Salmonella enterica serovar Enteritidis producing a TEM-52 β-lactamase: first report in Spain,” Diagnostic Microbiology and Infectious Disease, vol. 55, no. 3, pp. 245-246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. L. P. Randall, C. Clouting, R. A. Horton et al., “Prevalence of Escherichia coli carrying extended-spectrum β-lactamases (CTX-M and TEM-52) from broiler chickens and turkeys in Great Britain between 2006 and 2009,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 1, Article ID dkq396, pp. 86–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Perilli, B. Segatore, C. Mugnaioli et al., “Persistence of TEM-52/TEM-92 and SHV-12 extended-spectrum β-lactamases in clinical isolates of enterobacteriaceae in Italy,” Microbial Drug Resistance, vol. 17, no. 4, pp. 521–524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. P. F. Harrison and J. Lederberg, Antimicrobial Resistance: Issues and Options, National Academies Press, 1998.
  79. S. B. Levy, “Antibiotic resistance: consequences of inaction,” Clinical Infectious Diseases, vol. 33, supplement 3, pp. S124–S129, 2001. View at Publisher · View at Google Scholar
  80. L. Jostins, S. Ripke, R. K. Weersma et al., “Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease,” in Nature, vol. 491, pp. 119–124, 119-124, 2012. View at Google Scholar
  81. R. Cantón, A. Novais, A. Valverde et al., “Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe,” Clinical Microbiology and Infection, vol. 14, supplement 1, pp. 144–153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. T. M. Coque, Â. Novais, A. Carattoli et al., “Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15,” Emerging Infectious Diseases, vol. 14, no. 2, pp. 195–200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Cantón and T. M. Coque, “The CTX-M β-lactamase pandemic,” Current Opinion in Microbiology, vol. 9, no. 5, pp. 466–475, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. M. H. M. Al-Agamy, M. S. E.-D. Ashour, and I. Wiegand, “First description of CTX-M β-lactamase-producing clinical Escherichia coli isolates from Egypt,” International Journal of Antimicrobial Agents, vol. 27, no. 6, pp. 545–548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. A. F. Tawfik, A. M. Alswailem, A. M. Shibl, and M. H. M. Al-Agamy, “Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia,” Microbial Drug Resistance, vol. 17, no. 3, pp. 383–388, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. H. S. Khanfar, K. M. Bindayna, A. C. Senok, and G. A. Botta, “Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings,” The Journal of Infection in Developing Countries, vol. 3, no. 4, pp. 295–299, 2009. View at Google Scholar · View at Scopus
  87. T. Yagi, H. Kurokawa, N. Shibata, K. Shibayama, and Y. Arakawa, “A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan,” FEMS Microbiology Letters, vol. 184, no. 1, pp. 53–56, 2000. View at Publisher · View at Google Scholar · View at Scopus
  88. N. H. Ryoo, E.-C. Kim, S. G. Hong et al., “Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea,” Journal of Antimicrobial Chemotherapy, vol. 56, no. 4, pp. 698–702, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. C. J. Munday, J. Xiong, C. Li, D. Shen, and P. M. Hawkey, “Dissemination of CTX-M type β-lactamases in Enterobacteriaceae isolates in the People's Republic of China,” International Journal of Antimicrobial Agents, vol. 23, no. 2, pp. 175–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. T. Ali, S. Ur Rahman, L. Zhang et al., “ESBL-producing Escherichia coli from cows suffering mastitis in China contain clinical class 1 integrons with CTX-M linked to ISCR1,” Frontiers in Microbiology, vol. 7, article no. 1931, 2016. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Ali, S. Ur Rahman, L. Zhang et al., “Characteristics and genetic diversity of multi-drug resistant extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from bovine mastitis,” Oncotarget, vol. 8, no. 52, pp. 90144–90163, 2017. View at Publisher · View at Google Scholar
  92. D. Mathai, P. R. Rhomberg, D. J. Biedenbach et al., “Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories,” Diagnostic Microbiology and Infectious Disease, vol. 44, no. 4, pp. 367–377, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. K. Jabeen, A. Zafar, and R. Hasan, “Frequency and sensitivity pattern of extended spectrum beta lactamase producing isolates in a tertiary care hospital laboratory of Pakistan,” Journal of the Pakistan Medical Association, vol. 55, no. 10, pp. 436–439, 2005. View at Google Scholar · View at Scopus
  94. Y. Hirakata, J. Matsuda, Y. Miyazaki et al., “Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002),” Diagnostic Microbiology and Infectious Disease, vol. 52, no. 4, pp. 323–329, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Adnan, H. Khan, J. Kashif et al., “Clonal expansion of sulfonamide resistant Escherichia coli isolates recovered from diarrheic calves,” Pakistan Veterinary Journal, vol. 37, no. 2, pp. 230–232, 2017. View at Google Scholar · View at Scopus
  96. U. Naseer and A. Sundsfjord, “The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones,” Microbial Drug Resistance, vol. 17, no. 1, pp. 83–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Mazel, “Integrons: agents of bacterial evolution,” Nature Reviews Microbiology, vol. 4, no. 8, pp. 608–620, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Peirano, A. K. Van Der Bij, D. B. Gregson, and J. D. D. Pitout, “Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region,” Journal of Clinical Microbiology, vol. 50, no. 2, pp. 294–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Hayes, “Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest,” Science, vol. 301, no. 5639, pp. 1496–1499, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. M. D. Tamang, H.-M. Nam, M. Gurung et al., “Molecular characterization of CTX-M β-lactamase and associated addiction systems in Escherichia coli circulating among cattle, farm workers, and the farm environment,” Applied and Environmental Microbiology, vol. 79, no. 13, pp. 3898–3905, 2013. View at Publisher · View at Google Scholar · View at Scopus